RedHill Biopharma | Rentekostnader



Interest Expense On Debt Endring Dato
Clal Biotechnology 2.42M 640K 2020-09
Compugen 1.28M 507K 2024-09
Cronos Group USD 0 7K 2024-09
Intra Cellular Therapies 5.97M 966K 2023-12
RedHill Biopharma 89.8K 31.69M 2024-06



RedHill Biopharma Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.